We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Warburg Pincus Capital Corporation IA | NYSE:WPCA | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.21 | 0 | 00:00:00 |
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Cayman Islands
|
001-40171
|
98-1572641
|
||
(State or other jurisdiction of
incorporation or organization)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
450 Lexington Avenue
New York, New York
|
10017
|
|
(Address Of Principal Executive Offices)
|
(Zip Code)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Units, each consisting of one Class A ordinary share, $0.0001 par value, and
one-fifth
of one redeemable warrant
|
WPCA.U
|
NYSE
|
||
Class A ordinary shares included as part of the units
|
WPCA
|
NYSE
|
||
Redeemable warrants included as part of the units
|
WPCA WS
|
NYSE
|
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer
|
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
|
|
|
|
Page
|
|
|
PART I. FINANCIAL INFORMATION
|
|
|||||
Item 1.
|
|
|
|
1
|
|
|
|
|
|
1
|
|
||
|
|
|
2
|
|
||
|
|
|
3
|
|
||
|
|
|
4
|
|
||
|
|
|
5
|
|
||
Item 2.
|
|
|
|
20
|
|
|
Item 3.
|
|
|
|
24
|
|
|
Item 4.
|
|
|
|
24
|
|
|
PART II. OTHER INFORMATION
|
|
|||||
Item 1.
|
|
|
|
25
|
|
|
Item 1A.
|
|
|
|
25
|
|
|
Item 2.
|
|
|
|
25
|
|
|
Item 3.
|
|
|
|
26
|
|
|
Item 4.
|
|
|
|
26
|
|
|
Item 5.
|
|
|
|
26
|
|
|
Item 6.
|
|
|
|
26
|
|
|
|
|
|
27
|
|
Item 1.
|
Condensed Financial Statements
|
September 30, 2021
|
December 31, 2020
|
|||||||
Assets:
|
(Unaudited)
|
|||||||
Current assets:
|
||||||||
Cash
|
$ | 1,642,450 | $ | — | ||||
Prepaid expenses
|
634,484 | 11,758 | ||||||
|
|
|
|
|||||
Total current assets
|
2,276,934 | 11,758 | ||||||
Deferred offering costs associated with initial public offering
|
— | 81,600 | ||||||
Investments held in Trust Account
|
283,431,128 | — | ||||||
|
|
|
|
|||||
Total Assets
|
$
|
285,708,062
|
|
$
|
93,358
|
|
||
|
|
|
|
|||||
Liabilities and Shareholders’ Equity
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$ | 17,103 | $ | — | ||||
Accrued expenses
|
745,375 | 81,600 | ||||||
|
|
|
|
|||||
Total current liabilities
|
762,478 | 81,600 | ||||||
Derivative warrant liabilities
|
12,248,710 | — | ||||||
Deferred underwriting commissions
|
9,919,751 | — | ||||||
|
|
|
|
|||||
Total liabilities
|
22,930,939 | 81,600 | ||||||
Commitments and Contingencies
|
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 28,342,178 and
-0-
|
283,421,780 | — | ||||||
Shareholders’ Equity (Deficit):
|
||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020
|
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized
|
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,085,544 and 7,187,500 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively
|
709 | 719 | ||||||
Additional
paid-in
capital
|
— | 24,281 | ||||||
Accumulated deficit
|
(20,645,366 | ) | (13,242 | ) | ||||
|
|
|
|
|||||
Total shareholders’ equity (deficit)
|
(20,644,657 | ) | 11,758 | |||||
|
|
|
|
|||||
Total Liabilities and Shareholders’ Equity
|
$
|
285,708,062
|
|
$
|
93,358
|
|
||
|
|
|
|
For the Three Months
Ended September 30, 2021 |
For the Nine Months
Ended September 30, 2021 |
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
General and administrative expenses
|
$ | 345,816 | $ | 895,456 | ||||
General and administrative expenses - related party
|
30,000 | 70,000 | ||||||
|
|
|
|
|||||
Loss from operations
|
(375,816 | ) | (965,456 | ) | ||||
Other income (expense)
|
||||||||
Change in fair value of derivative warrant liabilities
|
2,861,850 | 1,402,100 | ||||||
Offering costs associated with derivative warrant liabilities
|
— | (396,570 | ) | |||||
Income from investments held in Trust Account
|
4,317 | 9,347 | ||||||
|
|
|
|
|||||
Net income
|
$ | 2,490,351 | $ | 49,421 | ||||
|
|
|
|
|||||
Weighted average shares outstanding of Class A ordinary shares
|
28,342,178 | 20,872,224 | ||||||
|
|
|
|
|||||
Basic and diluted net income per share, Class A ordinary shares
|
0.07 | 0.00 | ||||||
|
|
|
|
|||||
Basic weighted average shares outstanding of Class B ordinary shares
|
7,085,544 | 6,758,060 | ||||||
|
|
|
|
|||||
Basic net income per share, Class B ordinary shares
|
0.07 | 0.00 | ||||||
|
|
|
|
|||||
Diluted weighted average shares outstanding of Class B ordinary shares
|
7,085,544 | 7,085,544 | ||||||
|
|
|
|
|||||
Diluted net income per share, Class B ordinary shares
|
0.07 | 0.00 | ||||||
|
|
|
|
Ordinary Shares
|
Additional
|
Total
|
||||||||||||||||||||||||||
Class A
|
Class B
|
Paid-in
|
Accumulated
|
Shareholders’
|
||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Equity (Deficit)
|
||||||||||||||||||||||
Balance - December 31, 2020
|
|
—
|
|
$
|
—
|
|
|
7,187,500
|
|
$
|
719
|
|
$
|
24,281
|
|
$
|
(13,242
|
)
|
$
|
11,758
|
|
|||||||
Excess cash received over the fair value of the private warrants
|
— | — | — | — | 1,546,670 | — | 1,546,670 | |||||||||||||||||||||
Accretion of Class A ordinary shares subject to possible redemption amount
|
— | — | — | — | (1,570,951 | ) | (18,402,183 | ) | (19,973,134 | ) | ||||||||||||||||||
Net income
|
— | — | — | — | — | 1,352,066 | 1,352,066 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (unaudited)
|
|
—
|
|
|
—
|
|
|
7,187,500
|
|
|
719
|
|
|
—
|
|
|
(17,063,359
|
)
|
|
(17,062,640
|
)
|
|||||||
Excess cash received over the fair value of the private warrants, over-allotment
|
— | — | — | — | 209,446 | — | 209,446 | |||||||||||||||||||||
Forfeiture of Class B ordinary shares
|
— | — | (101,956 | ) | (10 | ) | 10 | — | — | |||||||||||||||||||
Accretion of Class A ordi
n
ary shares subject to possible redemption amount, over-allotment
|
— | — | — | — | (209,456 | ) | (2,279,362 | ) | (2,488,818 | ) | ||||||||||||||||||
Net loss
|
— | — | — | — | — | (3,792,996 | ) | (3,792,996 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2021 (unaudited)
|
|
—
|
|
|
—
|
|
|
7,085,544
|
|
|
709
|
|
|
—
|
|
|
(23,135,717
|
)
|
|
(23,135,008
|
)
|
|||||||
Net income
|
— | — | — | — | 2,490,351 | 2,490,351 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2021 (unaudited)
|
|
—
|
|
$
|
—
|
|
|
7,085,544
|
|
$
|
709
|
|
$
|
—
|
|
$
|
(20,645,366
|
)
|
$
|
(20,644,657)
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities:
|
||||
Net income
|
$ | 49,421 | ||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||
Income from investments held in Trust Account
|
(9,347 | ) | ||
Change in fair value of derivative warrant liabilities
|
(1,402,100 | ) | ||
Offering costs associated with derivative warrant liabilities
|
396,570 | |||
General and administrative expenses paid by related party under promissory note
|
3,053 | |||
Changes in operating assets and liabilities:
|
||||
Prepaid expenses
|
(622,726 | ) | ||
Accounts payable
|
17,091 | |||
Accrued expenses
|
410,375 | |||
|
|
|||
Net cash used in operating activities
|
(1,157,663 | ) | ||
|
|
|||
Cash Flows from Investing Activities:
|
||||
Cash deposited in Trust Account
|
(283,421,780 | ) | ||
|
|
|||
Net cash used in investing activities
|
(283,421,780 | ) | ||
|
|
|||
Cash Flows from Financing Activities:
|
||||
Repayment of note payable to related party
|
(78,045 | ) | ||
Proceeds received from initial public offering
|
283,421,780 | |||
Proceeds received from private placement
|
8,668,435 | |||
Offering costs paid
|
(5,790,277 | ) | ||
|
|
|||
Net cash provided by financing activities
|
286,221,893 | |||
|
|
|||
Net increase in cash
|
1,642,450 | |||
Cash - beginning of the period
|
— | |||
|
|
|||
Cash - end of the period
|
$
|
1,642,450
|
|
|
|
|
|||
Supplemental disclosure of noncash financing activities:
|
||||
Offering costs included in accrued expenses
|
$ | 253,400 | ||
Offering costs paid by related party under promissory note
|
$ | 74,992 | ||
Deferred underwriting commissions
|
$ | 9,919,751 |
• |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
|
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
|
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
For the Three Months Ended
September 30, 2021 |
For the Nine Months Ended
September 30, 2021 |
|||||||||||||||
Class A
|
Class B
|
Class A
|
Class B
|
|||||||||||||
Basic net income per ordinary share:
|
||||||||||||||||
Numerator
|
||||||||||||||||
Allocation of net income
|
$ | 1,992,281 | $ | 498,070 | $ | 37,333 | $ | 12,088 | ||||||||
Denominator
|
||||||||||||||||
Basic weighted average ordinary shares outstanding
|
28,342,178 | 7,085,544 | 20,872,224 | 6,758,060 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic net income per ordinary share
|
$ | 0.07 | $ | 0.07 | $ | 0.00 | $ | 0.00 | ||||||||
|
|
|
|
|
|
|
|
For the Three Months Ended
September 30, 2021 |
For the Nine Months Ended
September 30, 2021 |
|||||||||||||||
Class A
|
Class B
|
Class A
|
Class B
|
|||||||||||||
Diluted net income per ordinary share:
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Allocation of net income
|
$ | 1,992,281 | $ | 498,070 | $ | 36,896 | $ | 12,088 | ||||||||
Denominator:
|
||||||||||||||||
Diluted weighted average ordinary shares outstanding
|
28,342,178 | 7,085,544 | 20,872,224 | 7,085,544 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted net income per ordinary share
|
$ | 0.07 | $ | 0.07 | $ | 0.00 | $ | 0.00 | ||||||||
|
|
|
|
|
|
|
|
Gross proceeds from Initial Public Offering
|
$ | 283,421,780 | ||
Less:
|
||||
Fair value of Public Warrants at issuance
|
(6,738,490 | ) | ||
Offering costs allocated to Class A ordinary shares subject to possible redemption
|
(15,723,462 | ) | ||
Plus:
|
||||
Accretion on Class A ordinary shares subject to possible redemption amount
|
22,461,952 | |||
|
|
|||
Class A ordinary shares subject to possible redemption
|
$ | 283,421,780 | ||
|
|
• |
in whole and not in part;
|
• |
at a price of $0.01 per warrant;
|
• |
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
|
• |
if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
|
• |
in whole and not in part;
|
• |
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares;
|
• |
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and
|
• |
if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above.
|
Description
|
Quoted Prices in Active
Markets (Level 1) |
Significant Other
Observable Inputs (Level 2) |
Significant Other
Unobservable Inputs (Level 3) |
|||||||||
Assets:
|
||||||||||||
Investments held in Trust Account—money market funds
|
$ | 283,431,128 | $ | — | $ | — | ||||||
Liabilities:
|
||||||||||||
Derivative warrant liabilities—Public warrants
|
$ | — | $ | — | $ | 6,065,230 | ||||||
Derivative warrant liabilities—Private placement warrants
|
$ | — | $ | — | $ | 6,183,480 |
March 9,
2021 |
March 31,
2021 |
June 30,
2021 |
September 30,
2021 |
|||||||||||||
Exercise price
|
$ | 11.50 | $ | 11.50 | $ | 11.50 | $ | 11.50 | ||||||||
Unit price
|
$ | 10.07 | $ | 10.08 | $ | 9.80 | $ | 9.82 | ||||||||
Volatility
|
17.0 | % | 14.5 | % | 19.1 | % | 16.3 | % | ||||||||
Term (years)
|
6.0 | 5.9 | 5.7 | 5.4 | ||||||||||||
Risk-free rate
|
1.03 | % | 1.15 | % | 0.99 | % | 1.05 | % |
Derivative warrant liabilities at January 1, 2021
|
$ | — | ||
Issuance of Public and Private Warrants
|
12,503,330 | |||
Change in fair value of derivative warrant liabilities
|
(1,860,000 | ) | ||
|
|
|||
Derivative warrant liabilities at March 31, 2021
|
10,643,330 | |||
Issuance of Public and Private Warrants—over-allotment
|
1,147,480 | |||
Change in fair value of derivative warrant liabilities
|
3,319,750 | |||
|
|
|||
Derivative warrant liabilities at June 30, 2021
|
15,110,560 | |||
Change in fair value of derivative warrant liabilities
|
(2,861,850 | ) | ||
|
|
|||
Derivative warrant liabilities at September 30, 2021
|
$ | 12,248,710 | ||
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds From Registered Securities.
|
Item 3.
|
Defaults Upon Senior Securities
|
Item 4.
|
Mine Safety Disclosures.
|
Item 5.
|
Other Information.
|
Item 6.
|
Exhibits.
|
* |
Filed herewith
|
+ |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
|
Dated: November 11, 2021 |
WARBURG PINCUS CAPITAL CORPORATION
I-A
|
|||||
By: |
/s/ Christopher H. Turner
|
|||||
Name: | Christopher H. Turner | |||||
Title: | Chief Executive Officer and Chairman of the Board of Directors |
1 Year Warburg Pincus Capital C... Chart |
1 Month Warburg Pincus Capital C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions